Page last updated: 2024-08-21

thiazoles and Anemia, Cooley's

thiazoles has been researched along with Anemia, Cooley's in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aydinok, Y; Berk, G; Cohen, AR; Giardina, PJ; Jeglinski, BI; Kuo, KH; Kwiatkowski, JL; Neufeld, EJ; Pietropaolo, K; Saliba, AN; Taher, AT; Viprakasit, V1
Bree, M; Dagher, R; Donovan, JM; Marquis, J; Plone, M1
Kontoghiorghes, GJ1

Reviews

1 review(s) available for thiazoles and Anemia, Cooley's

ArticleYear
Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
    Annals of the New York Academy of Sciences, 2005, Volume: 1054

    Topics: Administration, Oral; Animals; beta-Thalassemia; Carboxylic Acids; Chelation Therapy; Clinical Trials, Phase I as Topic; Dogs; Drug Evaluation, Preclinical; Feces; Humans; Iron; Iron Chelating Agents; Iron Overload; Macaca fascicularis; Molecular Structure; Rats; Thiazoles

2005

Trials

1 trial(s) available for thiazoles and Anemia, Cooley's

ArticleYear
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.
    American journal of hematology, 2017, Volume: 92, Issue:12

    Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Cyclohexanones; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Kidney Diseases; Middle Aged; Siderophores; Thiazoles; Young Adult

2017

Other Studies

1 other study(ies) available for thiazoles and Anemia, Cooley's

ArticleYear
New chelation therapies and emerging chelating drugs for the treatment of iron overload.
    Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1

    Topics: beta-Thalassemia; Carboxylic Acids; Clinical Trials as Topic; Deferiprone; Deferoxamine; Drug Design; Drug Therapy, Combination; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Thiazoles; Transfusion Reaction

2006